Unlocking the Missing Puzzle Piece in Cancer Real-World Data
We invite you to participate in Carevive OPT-IN®, a network if Carevive customers participating in tumor registries to collect Real-World cancer patient experience data using Carevive PROmpt
Carevive OPT-IN® is designed to provide you with:
- Remote, longitudinal symptom monitoring data from your cancer patients to mitigate the symptoms that cause emergency room visits and extended hospitalizations. Benchmarking for continuous quality improvement.
- Summary insights of Carevive’s Cancer Patient Experience Database (by cancer type.) Expert commentary by industry leaders including Ethan Basch, MD and participating OPT-IN® thought leader investigators on insight impact on clinical practice and research.
- Contributions to quarterly data analyses, publications and scientific meeting presentations
- Participating with pharma in protocol-based investigations that emerge from these datasets
- Per patient grants for contributing patients to the OPT-IN registry.
- Data is easily collected as part of routine care from the EHR integrated Carevive remote symptom monitoring PROmpt platform.
Why are cancer centers choosing to OPT-IN with Carevive?
- Carevive Remote symptom monitoring improves clinical outcomes*
- Carevive OPT-IN® is the first network designed to bring these benefits to real-world patients as part of routine care.
* Basch, J Clin Oncol 2016; 34:557-565
Tumor registries to be initiated in 2020-2022
Myeloma
LIVE
Chronic Lymphocytic Leukemia
Renal Cell Carcinoma
Breast Cancer
LIVE
DLBCL
Follicular Lymphoma
Urothelial
Lung Cancer
LIVE
Ovarian Cancer
LIVE
Hepatocellular Carcinoma
Prostate Cancer
AML
LIVE
Stomach Cancer
Colorectal Carcinoma
Pancreatic Cancer
Head and Neck
OPT-imizing Patient Experience Data
